1,284
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation

, , , , , & show all
Pages 145-149 | Received 07 Oct 2010, Accepted 02 Dec 2010, Published online: 04 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Johan Ljungberg, Bengt Johansson, Ingvar A. Bergdahl, Anders Holmgren, Ulf Näslund, Johan Hultdin & Stefan Söderberg. (2019) Mild impairment of renal function (shrunken pore syndrome) is associated with increased risk for future surgery for aortic stenosis. Scandinavian Journal of Clinical and Laboratory Investigation 79:7, pages 524-530.
Read now
Emil den Bakker, Reinoud J. B. J. Gemke & Arend Bökenkamp. (2018) Endogenous markers for kidney function in children: a review. Critical Reviews in Clinical Laboratory Sciences 55:3, pages 163-183.
Read now
Alain Dardashti, Shahab Nozohoor, Anders Grubb & Henrik Bjursten. (2016) Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting. Scandinavian Journal of Clinical and Laboratory Investigation 76:1, pages 74-81.
Read now
Anders Grubb, Veronica Lindström, Magnus Jonsson, Sten-Erik Bäck, Tomas Åhlund, Bengt Rippe & Anders Christensson. (2015) Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: ‘Shrunken pore syndrome’. Scandinavian Journal of Clinical and Laboratory Investigation 75:4, pages 333-340.
Read now

Articles from other publishers (58)

Jingjing Tu, Ying Xu, Xu Guo, Jiayu Zhang, Duo Xu, Liyuan Han, Yue Wang, Boya Zhang & Hongpeng Sun. (2023) No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank. Frontiers in Medicine 10.
Crossref
Reuben Roy, John MacDonald, Paul Dark, Philip A Kalra & Darren Green. (2023) The estimation of glomerular filtration in acute and critical illness: Challenges and opportunities. Clinical Biochemistry 118, pages 110608.
Crossref
Xiao Zhang, Jason L Sanders, Robert M Boudreau, Alice M Arnold, Jamie N Justice, Mark A Espeland, George A Kuchel, Nir Barzilai, Lewis H Kuller, Oscar L Lopez, Stephen B Kritchevsky & Anne B Newman. (2023) Association of a Blood-Based Aging Biomarker Index With Death and Chronic Disease: Cardiovascular Health Study. The Journals of Gerontology: Series A.
Crossref
Borja Quiroga, Alberto Ortiz & Javier Díez. (2023) Selective glomerular hypofiltration syndrome. Nephrology Dialysis Transplantation.
Crossref
Linnea Malmgren, Carl Öberg, Emil den Bakker, Felicia Leion, Joanna Siódmiak, Anna Åkesson, Veronica Lindström, Erik Herou, Alain Dardashti, Liana Xhakollari, Gabriel Grubb, Helena Strevens, Magnus Abrahamson, Johanna Helmersson‐Karlqvist, Martin Magnusson, Jonas Björk, Ulf Nyman, Johan Ärnlöv, Peter Ridefelt, Torbjörn Åkerfeldt, Magnus Hansson, Anna Sjöström, Johan Mårtensson, Yoshihisa Itoh, David Grubb, Olav Tenstad, Lars‐Olov Hansson, Isleifur Olafsson, Araceli Jarquin Campos, Martin Risch, Lorenz Risch, Anders Larsson, Gunnar Nordin, Hans Pottel, Anders Christensson, Henrik Bjursten, Arend Bökenkamp & Anders Grubb. (2022) The complexity of kidney disease and diagnosing it – cystatin C, selective glomerular hypofiltration syndromes and proteome regulation. Journal of Internal Medicine 293:3, pages 293-308.
Crossref
Debbie C. Chen, Jennifer S. Lees, Kaiwei Lu, Rebecca Scherzer, Elaine Rutherford, Patrick B. Mark, Alka M. Kanaya, Michael G. Shlipak & Michelle M. Estrella. (2023) Differential Associations of Cystatin C Versus Creatinine‐Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank. Journal of the American Heart Association 12:3.
Crossref
Erik Linné, Alma Elfström, Anna Åkesson, Jane Fisher, Anders Grubb, Ville Pettilä, Suvi T. Vaara, Adam Linder & Peter Bentzer. (2022) Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort. Journal of Critical Care 72, pages 154148.
Crossref
Debbie C. Chen, O. Alison Potok, Dena Rifkin & Michelle M. Estrella. (2022) Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR. Kidney360 3:10, pages 1807-1814.
Crossref
Erik Dahlén & Linda Björkhem-Bergman. (2022) Comparison of Creatinine and Cystatin C to Estimate Renal Function in Geriatric and Frail Patients. Life 12:6, pages 846.
Crossref
Johanna Helmersson-Karlqvist, Miklos Lipcsey, Johan Ärnlöv, Max Bell, Bo Ravn, Alain Dardashti & Anders Larsson. (2022) Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care. Heart 108:4, pages 279-284.
Crossref
Vijayendran Govindasamy, Abilashini Rajendran, Zhi–Xin Lee, Ghee‐Chien Ooi, Kong‐Yong Then, Khong‐Lek Then, Merilynn Gayathri, Anjan Kumar Das & Soon‐Keng Cheong. (2021) The potential role of mesenchymal stem cells in modulating antiageing process. Cell Biology International 45:10, pages 1999-2016.
Crossref
Johanna Helmersson-Karlqvist, Miklos Lipcsey, Johan Ärnlöv, Max Bell, Bo Ravn, Alain Dardashti & Anders Larsson. (2021) Cystatin C predicts long term mortality better than creatinine in a nationwide study of intensive care patients. Scientific Reports 11:1.
Crossref
Iacopo Iacomelli, Antonella Giordano, Giulia Rivasi, Martina Rafanelli, Virginia Tortù, Alessandro Cartei, Carlo Rostagno, Mauro Di Bari, Niccolò Marchionni, Enrico Mossello & Andrea Ungar. (2021) Low Creatinine Potentially Overestimates Glomerular Filtration Rate in Older Fracture Patients: A Plea for an Extensive Use of Cystatin C?. European Journal of Internal Medicine 84, pages 74-79.
Crossref
Anders Grubb. (2020) Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options. Clinical Biochemistry 83, pages 12-20.
Crossref
Inês Castro & Anabela Rodrigues. (2020) Estimating Residual Kidney Function: Present and Future Challenge. SN Comprehensive Clinical Medicine 2:2, pages 140-148.
Crossref
Ren Zhang, Ming Chen, Tao-tao Liu, Jie-Jiu Lu & Chun-le Lv. (2019) Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population. European Journal of Drug Metabolism and Pharmacokinetics 45:1, pages 135-149.
Crossref
Tao Zhang. 2020. Chronic Kidney Disease. Chronic Kidney Disease 71 82 .
Yingchun Wang, Guoliang Wang, Keming Zhou, Nuerguli Maimaiti, Ting Wu, Kaiyang Wang & Jina Yili. 2020. Secondary Hypertension. Secondary Hypertension 65 122 .
Bo Ravn, Claire Rimes-Stigare, Max Bell, Magnus Hansson, Lars-Olof Hansson, Claes-Roland Martling, Anders Larsson & Johan Mårtensson. (2019) Creatinine versus cystatin C based glomerular filtration rate in critically ill patients. Journal of Critical Care 52, pages 136-140.
Crossref
Markus Sällman Almén, Jonas Björk, Ulf Nyman, Veronica Lindström, Magnus Jonsson, Magnus Abrahamson, AnnaLotta Schiller Vestergren, Örjan Lindhe, Gary Franklin, Anders Christensson & Anders Grubb. (2019) Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins. Kidney International Reports 4:1, pages 67-79.
Crossref
Sue M. Ford. 2019. Biomarkers in Toxicology. Biomarkers in Toxicology 267 275 .
Helen Legrand, Karin Werner, Anders Christensson, Mats Pihlsgård & Sölve Elmståhl. (2017) Prevalence and determinants of differences in cystatin C and creatinine-based estimated glomerular filtration rate in community-dwelling older adults: a cross-sectional study. BMC Nephrology 18:1.
Crossref
Cathrin L. Salvador, Anders Hartmann, Anders Åsberg, Stein Bergan, Alexander D. Rowe & Lars Mørkrid. (2017) Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population. Transplantation Direct 3:12, pages e332.
Crossref
Péter Kustán, Balázs Szirmay, Tamás Kőszegi, Andrea Ludány, Gábor L. Kovács, Attila Miseta, Diána Mühl, Balázs Németh, István Kiss, Ádám Németh, Sándor Szabados & Zénó Ajtay. (2017) Monitoring urinary orosomucoid in patients undergoing cardiac surgery: A promising novel inflammatory marker. Clinical Biochemistry 50:18, pages 1002-1006.
Crossref
Bo RavnJohn R. Prowle, Johan MårtenssonClaes-Roland MartlingMax Bell. (2017) Superiority of Serum Cystatin C Over Creatinine in Prediction of Long-Term Prognosis at Discharge From ICU. Critical Care Medicine 45:9, pages e932-e940.
Crossref
Anne Jacobs, Carolien Benraad, Jack Wetzels, Marcel Olde Rikkert & Cornelis Kramers. (2017) Clinical Relevance of Differences in Glomerular Filtration Rate Estimations in Frail Older People by Creatinine- vs. Cystatin C-Based Formulae. Drugs & Aging 34:6, pages 445-452.
Crossref
Per-Ola Sundin, Per Sjöström, Ian Jones, Lovisa A. Olsson, Ruzan Udumyan, Anders Grubb, Veronica Lindström & Scott Montgomery. (2017) Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine. Nephrology Dialysis Transplantation 32:4, pages 663-670.
Crossref
Song Yang, Jing Cai, Rulan Lu, Jian Wu, Min Zhang & Xianju Zhou. (2017) Association Between Serum Cystatin C Level and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients With Acute Lacunar Stroke. Journal of Stroke and Cerebrovascular Diseases 26:1, pages 186-191.
Crossref
A. Grubb. 2017. Biomarkers of Kidney Disease. Biomarkers of Kidney Disease 225 240 .
Bo Ravn, Anders Larsson, Johan Mårtensson, Claes-Roland Martling & Max Bell. (2016) Intra-day variability of cystatin C, creatinine and estimated GFR in intensive care patients. Clinica Chimica Acta 460, pages 1-4.
Crossref
Xingmin Wang. (2014) Subjective well-being associated with size of social network and social support of elderly. Journal of Health Psychology 21:6, pages 1037-1042.
Crossref
Tariq Shafi, Wieneke M. Michels, Andrew S. Levey, Lesley A. Inker, Friedo W. Dekker, Raymond T. Krediet, Tiny Hoekstra, George J. Schwartz, John H. Eckfeldt & Josef Coresh. (2016) Estimating residual kidney function in dialysis patients without urine collection. Kidney International 89:5, pages 1099-1110.
Crossref
Serap Çuhadar. 2016. Biomarkers in Kidney Disease. Biomarkers in Kidney Disease 445 461 .
Johan Mårtensson & Rinaldo Bellomo. (2015) Perioperative renal failure in elderly patients. Current Opinion in Anaesthesiology 28:2, pages 123-130.
Crossref
A. Grubb & M. Bell. (2015) Cystatin C: More than a renal function marker. Revista Clínica Española 215:2, pages 102-103.
Crossref
Manjula Gowrishankar, Christina VanderPluym, Cheri Robert, Fiona Bamforth, Susan Gilmour & Ambikaipakan Senthilselvan. (2014) Value of serum cystatin C in estimating renal function in children with non‐renal solid organ transplantation . Pediatric Transplantation 19:1, pages 27-34.
Crossref
Serap Çuhadar. 2015. Biomarkers in Kidney Disease. Biomarkers in Kidney Disease 1 17 .
Mi-Young Oh, Hyon Lee, Joon Soon Kim, Wi-Sun Ryu, Seung-Hoon Lee, Sang-Bae Ko, Chulho Kim, Chang Hun Kim & Byung-Woo Yoon. (2014) Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds. BMC Neurology 14:1.
Crossref
Ellen K. Hoogeveen, Johanna M. Geleijnse, Daan Kromhout, Theo Stijnen, Eugenie F. Gemen, Ron Kusters & Erik J. Giltay. (2014) Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction. Clinical Journal of the American Society of Nephrology 9:10, pages 1676-1683.
Crossref
Meng Zhang, Shu-Hong Fu, Hua Cui, Bing-Po Zhu, Lin Liu & De-Long Wang. (2013) Serum cystatin C and indices of lung function in elderly Chinese men with chronic obstructive pulmonary disease. Aging Clinical and Experimental Research 26:2, pages 193-199.
Crossref
Si?n P. Cartland, Jonathan H. Erlich & Mary M. Kavurma. (2014) TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE-/- Mice. PLoS ONE 9:3, pages e92952.
Crossref
W. -G. Zhang, X. -J. Bai, X. -F. Sun, G. -Y. Cai, X. -Y. Bai, S. -Y. Zhu, M. Zhang & Xiang-Mei Chen. (2013) Construction of an integral formula of biological age for a healthy Chinese population using principle component analysis. The journal of nutrition, health & aging 18:2, pages 137-142.
Crossref
Sue M. Ford. 2014. Biomarkers in Toxicology. Biomarkers in Toxicology 261 267 .
João Victor Salgado, Francival Leite Souza & Bernardete Jorge Salgado. (2013) How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?. Journal of Cardiology 62:6, pages 331-335.
Crossref
Lisa Sze, René L. Bernays, Cornelia Zwimpfer, Peter Wiesli, Michael Brändle & Christoph Schmid. (2013) Impact of Growth Hormone on Cystatin C. Nephron Extra 3:1, pages 118-124.
Crossref
Marta Spodzieja, Monika Rafalik, Aneta Szymańska, Aleksandra S. Kołodziejczyk & Paulina Czaplewska. (2013) Interaction of serum amyloid A with human cystatin C-assessment of amino acid residues crucial for hCC-SAA formation (part II). Journal of Molecular Recognition 26:9, pages 415-425.
Crossref
A. Vigil Medina, A. Oliet Palá & P. Gallar Ruiz. (2013) Cistatina C, ¿algo más que la estimación del filtrado glomerular?. Hipertensión y Riesgo Vascular 30:2, pages 58-69.
Crossref
Olivera Marsenic, Andrea Wierenga, Donna R. Wilson, Michael Anderson, Tripti Shrivastava, Garfield A. Simon, Anne M. Beck, Tiffany J. Swanson, Kathleen Studnicka, Dorit Elberg, Kevin Couloures & Martin A. Turman. (2012) Cystatin C in children on chronic hemodialysis. Pediatric Nephrology 28:4, pages 647-653.
Crossref
João Victor Salgado, Ana Karina França, Nayra Anielly Cabral, Joyce Lages, Valdinar Sousa Ribeiro, Alcione Miranda Santos & Bernardete Jorge Salgado. (2013) Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension. Revista da Associação Médica Brasileira 59:1, pages 21-27.
Crossref
João Victor Salgado, Ana Karina França, Nayra Anielly Cabral, Joyce Lages, Valdinar Sousa Ribeiro, Alcione Miranda Santos & Bernardete Jorge Salgado. (2013) Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension. Revista da Associação Médica Brasileira (English Edition) 59:1, pages 21-27.
Crossref
Marta Spodzieja, Aneta Szymańska, Aleksandra Kołodziejczyk, Martyna Prądzińska, Martyna Maszota, Piotr Stefanowicz, Zbigniew Szewczuk, Anders Grubb & Paulina Czaplewska. (2012) Interaction of serum amyloid A with human cystatin C—identification of binding sites. Journal of Molecular Recognition 25:10, pages 513-524.
Crossref
Amanda Hyre Anderson, Wei Yang, Chi-yuan Hsu, Marshall M. Joffe, Mary B. Leonard, Dawei Xie, Jing Chen, Tom Greene, Bernard G. Jaar, Patricia Kao, John W. Kusek, J. Richard Landis, James P. Lash, Raymond R. Townsend, Matthew R. Weir & Harold I. Feldman. (2012) Estimating GFR Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases 60:2, pages 250-261.
Crossref
Janet E Flatley, Clare M Garner, Maha Al-Turki, Nigel J Manning, Simon E Olpin, Margo E Barker & Hilary J Powers. (2012) Determinants of urinary methylmalonic acid concentration in an elderly population in the United Kingdom. The American Journal of Clinical Nutrition 95:3, pages 686-693.
Crossref
GEN OHARA, KUNIHIKO MIYAZAKI, KOICHI KURISHIMA, KATSUNORI KAGOHASHI, HIROICHI ISHIKAWA, HIROAKI SATOH & NOBUYUKI HIZAWA. (2012) Serum levels of cystatin C in elderly lung cancer patients. Oncology Letters 3:2, pages 303-306.
Crossref
J. Martensson, C.-R. Martling, A. Oldner & M. Bell. (2011) Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients. Nephrology Dialysis Transplantation 27:2, pages 576-581.
Crossref
Lesley A. Inker & Aghogho Okparavero. (2011) Cystatin C as a marker of glomerular filtration rate. Current Opinion in Nephrology and Hypertension 20:6, pages 631-639.
Crossref
Anders Grubb. (2011) Cystatin C- and creatinine-based GFR-prediction equations for children and adults. Clinical Biochemistry 44:7, pages 501-502.
Crossref
Simona Ferraro, Giuseppe Marano, Elia M. Biganzoli, Patrizia Boracchi & Angelo S. Bongo. (2011) Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target. Clinical Chemistry and Laboratory Medicine 49:9.
Crossref